Patents Assigned to ALLAKOS INC.
  • Patent number: 11203638
    Abstract: The present disclosure provides methods for the treatment of an allergic ocular disease (e.g., allergic conjunctivitis, keratoconjunctivitis, or giant papillary conjunctivitis). In particular, the present disclosure provides methods for the treatment of an allergic ocular disease through administration of antibodies that bind to human Siglec-8 or compositions comprising said antibodies. The present disclosure also provides articles of manufacture or kits comprising antibodies that bind to human Siglec-8 for the treatment of an allergic ocular disease.
    Type: Grant
    Filed: May 4, 2018
    Date of Patent: December 21, 2021
    Assignee: ALLAKOS INC.
    Inventors: Christopher Robert Bebbington, Bradford Andrew Youngblood, Nenad Tomasevic
  • Patent number: 9546215
    Abstract: The invention provides humanized anti-Siglec-8 antibodies and their use in treating and preventing eosinophil-mediated disorders and/or mast cell-mediated disorders, as well as compositions and kits comprising the humanized anti-Siglec-8 antibodies.
    Type: Grant
    Filed: December 9, 2014
    Date of Patent: January 17, 2017
    Assignee: ALLAKOS INC.
    Inventors: Christopher R. Bebbington, Rustom Falahati, Carolina Rita Sousa Fernandes, David John Matthews, Nenad Tomasevic, Jason Williams, John Leung
  • Publication number: 20150203578
    Abstract: The invention provides humanized anti-Siglec-8 antibodies and their use in treating and preventing eosinophil-mediated disorders and/or mast cell-mediated disorders, as well as compositions and kits comprising the humanized anti-Siglec-8 antibodies.
    Type: Application
    Filed: December 9, 2014
    Publication date: July 23, 2015
    Applicant: ALLAKOS INC.
    Inventors: CHRISTOPHER R. BEBBINGTON, RUSTOM FALAHATI, CAROLINA RITA SOUSA FERNANDES, DAVID JOHN MATTHEWS, NENAD TOMASEVIC, JASON WILLIAMS, JOHN LEUNG